e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Sarcoidosis: from the bench to the bedside
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adalimumab treatment in patients with sarcoidosis: An open clinical trial using FDG-PET
N. Milman, N. Graudal, A. Jakobsen, B. Baslund (Copenhagen, Denmark)
Source:
Annual Congress 2010 - Sarcoidosis: from the bench to the bedside
Session:
Sarcoidosis: from the bench to the bedside
Session type:
Thematic Poster Session
Number:
764
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Milman, N. Graudal, A. Jakobsen, B. Baslund (Copenhagen, Denmark). Adalimumab treatment in patients with sarcoidosis: An open clinical trial using FDG-PET. Eur Respir J 2010; 36: Suppl. 54, 764
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial
Source: Eur Respir J 2008; 31: 1189-1196
Year: 2008
The role of phonophoresis in patients with COPD: a randomized clinical trial
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020
Infliximab therapy in patients with chronic progressive sarcoidosis – a retrospective follow-up study
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008
Long-term treatment with infliximab in patients with sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Safety and benefit of adjunctive systemic corticosteroid therapy in the management of severe, smear positive pulmonary tuberculosis (SSP-PTB); an interim analysis of a randomized controlled trial
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
Azithromycin for sarcoidosis cough: an open-label exploratory clinical trial
Source: ERJ Open Res, 6 (4) 00534-2020; 10.1183/23120541.00534-2020
Year: 2020
Patients’ adherence to chronic treatment in lung diseases: Preliminary data from a randomized controlled trial
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis
Source: Eur Respir J 2014; 44: 1296-1307
Year: 2014
Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J, 53 (3) 1800663; 10.1183/13993003.00663-2018
Year: 2019
Endosonography vs. conventional bronchoscopy for the diagnosis of sarcoidosis: A randomized controlled trial
Source: Annual Congress 2013 –New frontiers for EBUS-TBNA: the mediastinum and beyond
Year: 2013
Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial
Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018
Year: 2019
Heterogeneity of treatment response in bronchiectasis clinical trials
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
STEP-UP randomized controlled trial of vapor ablation in patients with severe emphysema: 12 month results
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
Source: Eur Respir J, 56 (6) 2002808; 10.1183/13993003.02808-2020
Year: 2020
Supplementation of N-acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Tocilizumab treatment for patients with Covid-19 pneumonia - a single centre observational study
Source: Virtual Congress 2021 – COVID - 19 treatments
Year: 2021
Our clinical experience in surgical therapy of patients with bronchiectasis
Source: Eur Respir J 2002; 20: Suppl. 38, 344s
Year: 2002
Economic evaluation of the impact of exacerbation frequency in COPD patients treated with single-inhaler triple therapy in Spain: The IMPACT trial
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Clinical evaluation and follow-up of patients with ILD
Source: International Congress 2014 – MS01 Interdisciplinary diagnosis and evaluation of interstitial lung disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept